Not applicableStudy completedNCT02308488What this trial is testingStudy of Prone Accelerated Breast And Nodal IMRTWho this might be right forLymphedema NYU Langone Health 97
Large-scale testing (Phase 3)Ended earlyNCT00312442What this trial is testingPhase II/III Study of WST09 in Prostate Cancer After Radiation TherapyWho this might be right forProstate Cancer STEBA France 16
Large-scale testing (Phase 3)Not Yet RecruitingNCT07739186What this trial is testingA Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)Who this might be right forNon-squamous Non-small Cell Lung Cancer Sichuan Baili Pharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04792073What this trial is testingStudy of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell CarcinomaWho this might be right forMerkel Cell Carcinoma Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00024466What this trial is testingChemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple MyelomaWho this might be right forMultiple Myeloma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Testing effectiveness (Phase 2)Study completedNCT00027742What this trial is testingTemozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin) Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00014586What this trial is testingBicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer European Organisation for Research and Treatment of Cancer - EORTC 110
Testing effectiveness (Phase 2)Study completedNCT02857569What this trial is testingA Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic MelanomaWho this might be right forStage III/IV Melanoma Gustave Roussy, Cancer Campus, Grand Paris 90
Large-scale testing (Phase 3)Looking for participantsNCT06755554What this trial is testingInvestigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric CancerWho this might be right forGastric Cancer Stage IIGastric Cancer Stage IIIGastric Cancer+1 more Ukrainian Society of Clinical Oncology 105
Very early researchStudy completedNCT03387553What this trial is testingHER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast CancerWho this might be right forBreast CancerBreast Cancer FemaleBreast Cancer, Male+5 more H. Lee Moffitt Cancer Center and Research Institute 31
Testing effectiveness (Phase 2)Study completedNCT00005961What this trial is testingO6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic MelanomaWho this might be right forMelanoma (Skin) National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Ended earlyNCT00496756What this trial is testingSorafenib in Treating Patients With Metastatic or Unresectable Kidney CancerWho this might be right forKidney Cancer University of Nebraska 14
Not applicableStudy completedNCT02724488What this trial is testingSelection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic TherapiesWho this might be right forHead and Neck CancerMelanoma University Health Network, Toronto 14
Testing effectiveness (Phase 2)Ended earlyNCT00880542What this trial is testingSorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by SurgeryWho this might be right forSarcoma Jonsson Comprehensive Cancer Center 7
Not applicableStudy completedNCT02846870What this trial is testingVisually Enhanced Education About Prostate CancerWho this might be right forStage I Prostate CancerStage II Prostate CancerStage III Prostate Cancer Vanderbilt-Ingram Cancer Center 30
Early research (Phase 1)Study completedNCT00033241What this trial is testingErlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid TumorsWho this might be right forPancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific OSI Pharmaceuticals
Large-scale testing (Phase 3)Active Not RecruitingNCT03367702What this trial is testingStereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate CancerWho this might be right forStage II Prostate Adenocarcinoma AJCC v7 NRG Oncology 692
Not applicableStudy completedNCT03523195What this trial is testingExercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer SurvivorsWho this might be right forAnatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+16 more Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00227539What this trial is testingPositron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung CancerWho this might be right forLung Cancer University of Washington 25
Early research (Phase 1)Ended earlyNCT00369629What this trial is testingGemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary SyndromeWho this might be right forLymphoma Northwestern University 14